Research statistics

GHRP-6 research: publications and trials

What has been published on GHRP-6: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether GHRP-6 works or is safe. For what it is and what the studies found, see the GHRP-6 profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

412

Since 1988

Publications in 2026 so far

8

Through November 15, 2026

Human clinical research

21.1%

87 of 412 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

17

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

73.8%

236 animal · 65 in vitro · 3 computational

Records that only mention it

297

Not counted above

Status in the library: Research only. Groups: Growth hormone axis.

What to keep in mind

  • More than 70% of the indexed publications are animal, cell or computational studies.

Publications by year

GHRP-6 publications by year and evidence

1988, Preclinical (animal, in vitro, computational): 1 of 11989, Preclinical (animal, in vitro, computational): 2 of 21990, Preclinical (animal, in vitro, computational): 2 of 21991, Preclinical (animal, in vitro, computational): 5 of 51992, Preclinical (animal, in vitro, computational): 2 of 21993, Human clinical research: 5 of 121993, Preclinical (animal, in vitro, computational): 4 of 121993, Reviews and meta-analyses: 3 of 121994, Human clinical research: 4 of 111994, Preclinical (animal, in vitro, computational): 7 of 111995, Human clinical research: 9 of 201995, Preclinical (animal, in vitro, computational): 11 of 201996, Human clinical research: 6 of 181996, Preclinical (animal, in vitro, computational): 8 of 181996, Reviews and meta-analyses: 4 of 181997, Human clinical research: 4 of 181997, Preclinical (animal, in vitro, computational): 11 of 181997, Reviews and meta-analyses: 3 of 181998, Human clinical research: 6 of 191998, Preclinical (animal, in vitro, computational): 10 of 191998, Reviews and meta-analyses: 3 of 191999, Human clinical research: 3 of 121999, Preclinical (animal, in vitro, computational): 8 of 121999, Reviews and meta-analyses: 1 of 122000, Human clinical research: 2 of 102000, Preclinical (animal, in vitro, computational): 7 of 102000, Reviews and meta-analyses: 1 of 102001, Human clinical research: 4 of 122001, Preclinical (animal, in vitro, computational): 8 of 122002, Human clinical research: 6 of 112002, Preclinical (animal, in vitro, computational): 5 of 112003, Human clinical research: 8 of 142003, Preclinical (animal, in vitro, computational): 6 of 142004, Human clinical research: 4 of 112004, Preclinical (animal, in vitro, computational): 7 of 112005, Human clinical research: 1 of 102005, Preclinical (animal, in vitro, computational): 9 of 102006, Human clinical research: 4 of 112006, Preclinical (animal, in vitro, computational): 7 of 112007, Human clinical research: 5 of 152007, Preclinical (animal, in vitro, computational): 10 of 152008, Human clinical research: 3 of 132008, Preclinical (animal, in vitro, computational): 10 of 132009, Human clinical research: 5 of 152009, Preclinical (animal, in vitro, computational): 10 of 152010, Human clinical research: 3 of 132010, Preclinical (animal, in vitro, computational): 10 of 132011, Preclinical (animal, in vitro, computational): 19 of 202011, Reviews and meta-analyses: 1 of 202012, Human clinical research: 1 of 132012, Preclinical (animal, in vitro, computational): 12 of 132013, Preclinical (animal, in vitro, computational): 11 of 122013, Other and not yet classified: 1 of 122014, Preclinical (animal, in vitro, computational): 17 of 172015, Human clinical research: 1 of 112015, Preclinical (animal, in vitro, computational): 10 of 112016, Preclinical (animal, in vitro, computational): 8 of 82017, Human clinical research: 1 of 82017, Preclinical (animal, in vitro, computational): 7 of 82018, Preclinical (animal, in vitro, computational): 6 of 72018, Other and not yet classified: 1 of 72019, Preclinical (animal, in vitro, computational): 6 of 62020, Preclinical (animal, in vitro, computational): 10 of 122020, Reviews and meta-analyses: 2 of 122021, Preclinical (animal, in vitro, computational): 8 of 82022, Preclinical (animal, in vitro, computational): 7 of 72023, Preclinical (animal, in vitro, computational): 5 of 52024, Human clinical research: 1 of 52024, Preclinical (animal, in vitro, computational): 4 of 52025, Preclinical (animal, in vitro, computational): 8 of 82026 (to date), Human clinical research: 1 of 82026 (to date), Preclinical (animal, in vitro, computational): 6 of 82026 (to date), Reviews and meta-analyses: 1 of 8Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified05101520198819962004201220202026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
198801001
198902002
199002002
199105005
199202002
1993543012
1994470011
19959110020
1996684018
19974113018
19986103019
1999381012
2000271010
2001480012
2002650011
2003860014
2004470011
2005190010
2006470011
20075100015
20083100013
20095100015
20103100013
20110191020
20121120013
20130110112
20140170017
20151100011
201608008
201717008
201806017
201906006
20200102012
202108008
202207007
202305005
202414005
202508008
2026 (to date)16108

Study types

Animal study236
In vitro study65
Other clinical trial58
Review19
Randomized controlled trial17
Observational human study9
Case report3
Computational study3
Editorial, letter or other2

Research areas

From MeSH major topics. A paper can be in several areas.

Endocrinology195
Neurological and mental health147
Metabolic health60
Obesity and weight management41
Cardiovascular28
Gastrointestinal26
Musculoskeletal23
Oncology23
Immune system21
Longevity and aging17
Cognitive health16
Reproductive and sexual health15

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · July 16, 2026 · Randomized controlled trial · cited 0 times

    PMID 42462342 · DOI 10.1016/j.jocn.2026.112195 · Human clinical research

  2. Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial.

    Frontiers in neurology · April 4, 2024 · Randomized controlled trial · cited 6 times · open access

    PMID 38638315 · DOI 10.3389/fneur.2024.1303402 · Human clinical research

  3. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.

    Metabolism: clinical and experimental · March 1, 2010 · Randomized controlled trial · cited 8 times · open access

    PMID 20189610 · DOI 10.1016/j.metabol.2010.01.021 · Human clinical research

  4. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).

    Clinical endocrinology · April 29, 2009 · Randomized controlled trial · cited 9 times

    PMID 19453623 · DOI 10.1111/j.1365-2265.2009.03618.x · Human clinical research

  5. Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.

    Pituitary · January 1, 2007 · Randomized controlled trial · cited 6 times

    PMID 17410412 · DOI 10.1007/s11102-007-0005-2 · Human clinical research

  6. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.

    Journal of endocrinological investigation · March 1, 2003 · Randomized controlled trial · cited 13 times

    PMID 12809173 · DOI 10.1007/bf03345162 · Human clinical research

  7. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.

    Molecular and cellular endocrinology · November 1, 2002 · Randomized controlled trial · cited 17 times

    PMID 12431802 · DOI 10.1016/s0303-7207(02)00293-9 · Human clinical research

  8. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.

    Clinical endocrinology · October 1, 2001 · Randomized controlled trial · cited 12 times

    PMID 11678828 · DOI 10.1046/j.1365-2265.2001.01374.x · Human clinical research

  9. Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man.

    Clinical endocrinology · October 1, 1999 · Randomized controlled trial · cited 8 times · open access

    PMID 10583306 · DOI 10.1046/j.1365-2265.1999.00792.x · Human clinical research

  10. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.

    Metabolism: clinical and experimental · April 1, 1999 · Randomized controlled trial · cited 14 times

    PMID 10206449 · DOI 10.1016/s0026-0495(99)90115-4 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

Latest publications

  1. Ghrelin attenuates hypoxia-induced mitochondrial oxidative stress damage in HTR-8/SVneo trophoblasts.

    Tissue & cell · September 10, 2026 · In vitro study · cited 0 times · open access

    PMID 42753464 · DOI 10.1016/j.tice.2026.103950 · In vitro studies

  2. Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · July 16, 2026 · Randomized controlled trial · cited 0 times

    PMID 42462342 · DOI 10.1016/j.jocn.2026.112195 · Human clinical research

  3. EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences.

    Neurotoxicity research · July 4, 2026 · Animal study · cited 0 times

    PMID 42399524 · DOI 10.1007/s12640-026-00807-0 · Animal studies

  4. Ghrelin impairs embryo development after ovarian hyperstimulation.

    The Journal of endocrinology · July 1, 2026 · Animal study · cited 0 times

    PMID 42461148 · DOI 10.1530/joe-26-0041 · Animal studies

  5. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

    Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access

    PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses

  6. A discovery-based proteomic approach of epidermal growth factor and growth hormone-releasing peptide-6 in a model of acute ischemic stroke.

    Pharmacological reports : PR · June 8, 2026 · Animal study · cited 0 times

    PMID 42258095 · DOI 10.1007/s43440-026-00872-4 · Animal studies

  7. Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.

    Pharmaceuticals (Basel, Switzerland) · March 12, 2026 · Animal study · cited 0 times · open access

    PMID 41901314 · DOI 10.3390/ph19030468 · Animal studies

  8. Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis.

    International immunopharmacology · January 13, 2026 · Animal study · cited 0 times

    PMID 41534456 · DOI 10.1016/j.intimp.2026.116204 · Animal studies

  9. Effect of intracerebroventricular (ICV) injection of antimicrobial peptide expressed in the body-2 (LEAP-2) and its interaction with cannabinoid and ghrelin systems on food intake in broiler chickens.

    Poultry science · December 6, 2025 · Animal study · cited 1 times · open access

    PMID 41406822 · DOI 10.1016/j.psj.2025.106199 · Animal studies

  10. Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation.

    Journal of nanobiotechnology · December 1, 2025 · Animal study · cited 2 times · open access

    PMID 41327290 · DOI 10.1186/s12951-025-03888-9 · Animal studies

Browse all 412 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: GHRP-6; Growth hormone-releasing peptide-6

((TITLE_ABS:"GHRP-6" OR CHEM:"GHRP-6" OR TITLE_ABS:"GHRP6" OR CHEM:"GHRP6") OR (TITLE_ABS:"Growth hormone-releasing peptide-6" OR CHEM:"Growth hormone-releasing peptide-6" OR TITLE_ABS:"Growth hormone-releasing peptide6" OR CHEM:"Growth hormone-releasing peptide6")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). GHRP-6 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/ghrp-6